The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015.
Comparatively, Canopy Growth’s competitors have a beta of 2.57, meaning that their average share price is 157% more volatile than the S&P 500.
Canopy Growth is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Canopy Growth (NYSE: CGC) is one of 33 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it compare to its competitors?
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.